Kristin Rookey and Ross Connor join industry peers in Lisbon for the premier spring partnering conference.

Brad Lunde will present a poster on the discovery of transferrin receptor antibodies for targeted CNS delivery.

Adimab scientists will present two posters on novel VHH antibodies targeting CD3 and TCR for T cell engagement.

Aaron Sato, Chief Strategy Officer, will present Adimab's journey from startup to leading antibody platform.

William Roach hosts a table discussion on challenges and solutions in bi- and multispecific antibodies.

Brad Lunde and Aaron Sato moderate panel discussions for multispecifics and peptides.